Please try another search
Proactive Investors - AstraZeneca PLC (LON:AZN) shares fell to a five-month low after it confirmed that another failed cancer trial of its Dato-DXd drug. The largest company in the FTSE 100 said it...
CAMBRIDGE, UK - The U.S. Food and Drug Administration (FDA) has approved AstraZeneca (NASDAQ:AZN)'s FluMist, a needle-free nasal spray influenza vaccine, for self-administration at home for adults up...
Welcome to the Investing.com UK weekly FTSE 100 latest update, designed to keep investors informed on the newest UK stock market movements and key developments. In this weekly report, you'll find a...
Proactive Investors - AstraZeneca (LON:AZN) saw another £4 billion wiped off its value as top city firm Deutsche Bank (ETR:DBKGn) cut its recommendation to ‘sell’ following the...
Proactive Investors - FTSE 100 falls by 37 points AstraZeneca off nearly 5% UK jobs data mixed iPhone 16 met with relative indifference Apple Inc (NASDAQ:AAPL) shares are expected to lose around 1.1%...
Investing.com -- Shares of AstraZeneca (LON:AZN) dropped on Thursday following the presentation of disappointing final overall survival data from the TROPION-Lung-01 (TL-01) trial at the World...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review